{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:08:23Z","timestamp":1760144903122,"version":"build-2065373602"},"reference-count":78,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.cjca.2023.03.019","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T03:32:34Z","timestamp":1679628754000},"page":"865-874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["An Evolving Understanding of the Basis and Management of Vascular Complications of COVID-19: Where Do We Go From Here?"],"prefix":"10.1016","volume":"39","author":[{"given":"Yishay","family":"Szekely","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami","family":"Gilead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Beatriz B.A.C.","family":"R\u00e9a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick R.","family":"Lawler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2023.03.019_bib1","doi-asserted-by":"crossref","first-page":"E1156","DOI":"10.1503\/cmaj.201240","article-title":"Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19","volume":"192","author":"Godoy","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/j.cjca.2023.03.019_bib2","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/cvr\/cvaa230","article-title":"Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science","volume":"116","author":"Evans","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2023.03.019_bib3","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1161\/ATVBAHA.119.312580","article-title":"Endothelial response to pathophysiological stress","volume":"39","author":"Peng","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2023.03.019_bib4","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2023.03.019_bib5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/17446651.2021.1979392","article-title":"Does abdominal obesity influence immunological response to SARS-CoV-2 infection?","volume":"16","author":"Sanchis-Gomar","year":"2021","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.cjca.2023.03.019_bib6","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1016\/S2665-9913(20)30121-1","article-title":"Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia","volume":"2","author":"McGonagle","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.cjca.2023.03.019_bib7","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s11239-021-02593-2","article-title":"A\u00a0comprehensive review of vascular complications in COVID-19","volume":"53","author":"Acharya","year":"2022","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.cjca.2023.03.019_bib8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","article-title":"COVID-19: the vasculature unleashed","volume":"20","author":"Teuwen","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cjca.2023.03.019_bib9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/ajh.25829","article-title":"Hematological findings and complications of COVID-19","volume":"95","author":"Terpos","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cjca.2023.03.019_bib10","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.mayocp.2020.10.031","article-title":"Coronavirus disease 2019-associated coagulopathy","volume":"96","author":"Lippi","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cjca.2023.03.019_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.31083\/j.rcm.2020.03.126","article-title":"Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy","volume":"21","author":"Zhang","year":"2020","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.cjca.2023.03.019_bib12","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.4269\/ajtmh.20-1536","article-title":"Hematological abnormalities in COVID-19: a narrative review","volume":"104","author":"Rahman","year":"2021","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cjca.2023.03.019_bib13","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/CCM.0000000000005567","article-title":"The renin-angiotensin system in acute lung injury","volume":"50","author":"Lawler","year":"2022","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cjca.2023.03.019_bib14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00134-022-06634-z","article-title":"Sepsis hospitalization and risk of subsequent cardiovascular events in adults: a population-based matched cohort study","volume":"48","author":"Angriman","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cjca.2023.03.019_bib15","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00134-021-06479-y","article-title":"Association between sepsis survivorship and long-term cardiovascular outcomes in adults: a systematic review and meta-analysis","volume":"47","author":"Kosyakovsky","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cjca.2023.03.019_bib16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","article-title":"Long-term cardiovascular outcomes of COVID-19","volume":"28","author":"Xie","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.cjca.2023.03.019_bib17","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMra1312885","article-title":"Community-acquired pneumonia","volume":"371","author":"Musher","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2023.03.019_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJMra1808137","article-title":"Acute infection and myocardial infarction","volume":"380","author":"Musher","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2023.03.019_bib19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.thromres.2020.05.039","article-title":"Thrombosis risk associated with COVID-19 infection. A scoping review","volume":"192","author":"Al-Ani","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.cjca.2023.03.019_bib20","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1111\/jth.14888","article-title":"Incidence of venous thromboembolism in hospitalized patients with COVID-19","volume":"18","author":"Middeldorp","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.cjca.2023.03.019_bib21","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000023186","article-title":"Trends and diagnostic value of D-dimer levels in patients hospitalized with coronavirus disease 2019","volume":"99","author":"Creel-Bulos","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cjca.2023.03.019_bib22","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/rth2.12439","article-title":"Risk of venous thromboembolism in patients with COVID-19: a systematic review and meta-analysis","volume":"4","author":"Nopp","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.cjca.2023.03.019_bib23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/rth2.12496","article-title":"Risk of thrombotic complications in influenza versus COVID-19 hospitalized patients","volume":"5","author":"Stals","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.cjca.2023.03.019_bib24","article-title":"Risks of deep vein thrombosis, pulmonary embolism, and bleeding after COVID-19: nationwide self-controlled cases series and matched cohort study","volume":"377","author":"Katsoularis","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2023.03.019_bib25","first-page":"5549","article-title":"High versus standard intensity of thromboprophylaxis in hospitalized patients with COVID-19: a systematic review and meta-analysis","volume":"10","author":"Kollias","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.cjca.2023.03.019_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.35397","article-title":"Factors associated with risk of postdischarge thrombosis in patients with COVID-19","volume":"4","author":"Li","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cjca.2023.03.019_bib27","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1182\/blood.2020007938","article-title":"Postdischarge thrombosis and hemorrhage in patients with COVID-19","volume":"136","author":"Patell","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.cjca.2023.03.019_bib28","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1182\/blood.2020010529","article-title":"Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry","volume":"137","author":"Giannis","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.cjca.2023.03.019_bib29","article-title":"Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis","volume":"29","author":"Malas","year":"2020","journal-title":"EclinicalMedicine"},{"key":"10.1016\/j.cjca.2023.03.019_bib30","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/jama.2020.13372","article-title":"Thrombosis in hospitalized patients with COVID-19 in a New York City health system","volume":"324","author":"Bilaloglu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2023.03.019_bib31","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/CIRCULATIONAHA.122.060785","article-title":"Association of COVID-19 with major arterial and venous thrombotic diseases: a population-wide cohort study of 48 million adults in England and Wales","volume":"146","author":"Knight","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.03.019_bib32","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/STROKEAHA.121.035270","article-title":"Stroke among patients hospitalized with COVID-19: results from the American Heart Association COVID-19 Cardiovascular Disease Registry","volume":"53","author":"Shakil","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2023.03.019_bib33","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0140-6736(21)00896-5","article-title":"Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study","volume":"398","author":"Katsoularis","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2023.03.019_bib34","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1161\/CIRCULATIONAHA.120.050809","article-title":"Acute COVID-19 and the incidence of ischemic stroke and acute myocardial infarction","volume":"142","author":"Modin","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.03.019_bib35","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jvs.2021.07.222","article-title":"Acute limb ischemia among patients with COVID-19 infection","volume":"75","author":"Galyfos","year":"2022","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.cjca.2023.03.019_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14930","article-title":"Bowel ischemia in COVID-19: a systematic review","volume":"75","author":"Patel","year":"2021","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.cjca.2023.03.019_bib37","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s00261-021-03337-9","article-title":"Mesenteric ischemia in patients with COVID-19: an updated systematic review of abdominal CT findings in 75 patients","volume":"47","author":"Ojha","year":"2022","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.cjca.2023.03.019_bib38","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/CIRCULATIONAHA.120.048488","article-title":"Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy","volume":"142","author":"Nicolai","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.03.019_bib39","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2023.03.019_bib40","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMc2105869","article-title":"Thrombotic thrombocytopenia after Ad26.COV2.S vaccination","volume":"384","author":"Muir","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2023.03.019_bib41","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2023.03.019_bib42","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/a-1469-7481","article-title":"Diagnosis and management of vaccine-related thrombosis following AstraZeneca COVID-19 vaccination: guidance statement from the GTH","volume":"41","author":"Oldenburg","year":"2021","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.cjca.2023.03.019_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","article-title":"Sepsis and septic shock","volume":"392","author":"Cecconi","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2023.03.019_bib44","article-title":"Review: the emerging role of neutrophil extracellular traps in sepsis and sepsis-associated thrombosis","volume":"11","author":"Chen","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.cjca.2023.03.019_bib45","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1378\/chest.15-0287","article-title":"VTE incidence and risk factors in patients with severe sepsis and septic shock","volume":"148","author":"Kaplan","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.cjca.2023.03.019_bib46","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ahj.2020.10.075","article-title":"Thrombosis in hospitalized patients with viral respiratory infections versus COVID-19","volume":"231","author":"Smilowitz","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2023.03.019_bib47","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(06)68474-2","article-title":"Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting","volume":"367","author":"Smeeth","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2023.03.019_bib48","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1038\/s41598-021-83466-9","article-title":"Risk of thrombotic events after respiratory infection requiring hospitalization","volume":"11","author":"Smilowitz","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.cjca.2023.03.019_bib49","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1055\/s-0040-1713434","article-title":"Bleeding and bleeding risk in COVID-19","volume":"46","author":"Dorgalaleh","year":"2020","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.cjca.2023.03.019_bib50","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1182\/blood.2021012247","article-title":"Clinical features of thrombosis and bleeding in COVID-19","volume":"140","author":"Thomas","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.cjca.2023.03.019_bib51","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1182\/hematology.2021000297","article-title":"How to recognize and manage COVID-19-associated coagulopathy","volume":"2021","author":"Gerber","year":"2021","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.cjca.2023.03.019_bib52","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa2105911","article-title":"Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19","volume":"385","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2023.03.019_bib53","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic anticoagulation with heparin in critically ill patients with Covid-19","volume":"385","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2023.03.019_bib54","doi-asserted-by":"crossref","first-page":"n2400","DOI":"10.1136\/bmj.n2400","article-title":"Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial","volume":"375","author":"Sholzberg","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2023.03.019_bib55","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2023.02.041","article-title":"Anticoagulation strategies in non-critically ill patients hospitalized with COVID-19: a randomized clinical trial","volume":"81","author":"Stone","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2023.03.019_bib56","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jamainternmed.2021.6203","article-title":"Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19: the HEP-COVID randomized clinical trial","volume":"181","author":"Spyropoulos","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cjca.2023.03.019_bib57","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(21)01203-4","article-title":"Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with\u00a0COVID-19 and elevated D-dimer concentration (ACTION): an\u00a0open-label, multicentre, randomised, controlled trial","volume":"397","author":"Lopes","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2023.03.019_bib58","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1161\/CIRCULATIONAHA.122.061533","article-title":"Anticoagulation and antiplatelet therapy for prevention of venous and arterial thrombotic events in critically ill patients with COVID-19: COVID-PACT","volume":"146","author":"Bohula","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.03.019_bib59","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(21)01825-0","article-title":"Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2023.03.019_bib60","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood.2020006520","article-title":"COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection","volume":"136","author":"Al-Samkari","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.cjca.2023.03.019_bib61","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12959-022-00414-x","article-title":"Incidence, risk factors, and clinical impact of major bleeding in hospitalized patients with COVID-19: a sub-analysis of the CLOT-COVID Study","volume":"20","author":"Nakamura","year":"2022","journal-title":"Thromb J"},{"key":"10.1016\/j.cjca.2023.03.019_bib67","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1001\/jama.2021.4152","volume":"325","author":"INSPIRATION Investigators","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2023.03.019_bib77","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.2022.2910","article-title":"Effect of antiplatelet therapy on survival and organ support-free days in critically ill patients with COVID-19: a randomized clinical trial","volume":"327","author":"Bradbury","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2023.03.019_bib76","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1001\/jama.2021.17272","article-title":"Effect of antithrombotic therapy on clinical outcomes in outpatients with clinically stable symptomatic COVID-19: the ACTIV-4B randomized clinical trial","volume":"326","author":"Connors","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2023.03.019_bib71","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(21)02392-8","article-title":"Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial","volume":"399","author":"Ramacciotti","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2023.03.019_bib62","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1001\/jama.2021.4295","article-title":"Finding the optimal thromboprophylaxis dose in patients with COVID-19","volume":"325","author":"Al-Samkari","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2023.03.019_bib63","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/bloodadvances.2020003763","article-title":"American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19","volume":"5","author":"Cuker","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.cjca.2023.03.019_bib66","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200293","article-title":"Anticoagulation strategies in non\u2013critically ill patients with Covid-19","volume":"2","author":"McQuilten","year":"2023","journal-title":"NEJM Evidence"},{"key":"10.1016\/j.cjca.2023.03.019_bib68","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/CIRCULATIONAHA.122.061231","article-title":"Models for evidence generation during the COVID-19 pandemic: new opportunities for clinical trials in cardiovascular medicine","volume":"147","author":"Lawler","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.03.019_bib69","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1182\/bloodadvances.2021005963","article-title":"Emerging clinical trial designs may accelerate translation in hematology: lessons from COVID-19","volume":"6","author":"Neal","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.cjca.2023.03.019_bib70","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/CIRCULATIONAHA.121.058113","article-title":"What are adaptive platform clinical trials and what role may they have in cardiovascular medicine?","volume":"145","author":"Lawler","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2023.03.019_bib72","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.jacc.2020.04.071","article-title":"Post-discharge prophylaxis with rivaroxaban reduces fatal and major thromboembolic events in medically ill patients","volume":"75","author":"Spyropoulos","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2023.03.019_bib73","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/bloodadvances.2021005945","article-title":"American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis","volume":"6","author":"Cuker","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.cjca.2023.03.019_bib74","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1111\/jth.15808","article-title":"ISTH guidelines for antithrombotic treatment in COVID-19","volume":"20","author":"Schulman","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.cjca.2023.03.019_bib75","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2352-3026(22)00173-9","article-title":"Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial","volume":"9","author":"Cools","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.cjca.2023.03.019_bib78","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/jama.2021.23605","article-title":"Effect of P2Y12 inhibitors on survival free of organ support among non\u2013critically ill hospitalized patients with COVID-19: a randomized clinical trial","volume":"327","author":"Berger","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2023.03.019_bib80","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2022.23257","article-title":"Long-term (180-Day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial","volume":"329","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2023.03.019_bib81","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41581-022-00642-4","article-title":"Therapeutic advances in COVID-19","volume":"19","author":"Murakami","year":"2023","journal-title":"Nat Rev Nephrol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X23002726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X23002726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:51:57Z","timestamp":1760107917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X23002726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0828282X23002726"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2023.03.019","relation":{},"ISSN":["0828-282X"],"issn-type":[{"type":"print","value":"0828-282X"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Evolving Understanding of the Basis and Management of Vascular Complications of COVID-19: Where Do We Go From Here?","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2023.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}